Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer.
Journal: Journal for immunotherapy of cancer
Published: April 15, 2026
Regulating the regulators via targeting CD38 in the tumor microenvironment.
Journal: Frontiers in immunology
Published: November 13, 2025
Immunotherapy and Radiation for Clinical Perineural Invasion in Cutaneous Squamous Cell Carcinoma.
Journal: Cancers
Published: October 20, 2025
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study.
Journal: Journal for immunotherapy of cancer
Published: March 17, 2025
Novel Assessment of Advanced Practice Provider-Led Head and Neck Cancer Survivorship Clinic: Quality-of-Care Metric Analysis and HOUSES Index Application.
Journal: Head & neck
Published: January 28, 2025
The Proimmunomodulatory and Anti-immunomodulatory Effects of Radiotherapy in Oncologic Care.
Journal: Hematology/oncology clinics of North America
Published: January 18, 2025
Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study.
Journal: International journal of radiation oncology, biology, physics
Published: January 17, 2025
SIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling.
Journal: Nature immunology
Published: May 30, 2024
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy.
Journal: Nature cancer
Published: January 09, 2024
Quality of life and patient-reported toxicities in patients with advanced Merkel cell carcinoma treated with combined nivolumab and ipilimumab with or without stereotactic body radiation therapy.
Journal: Cancer medicine
Published: November 29, 2023
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy.
Journal: Cancer discovery
Published: July 14, 2023
Last Updated: 09/26/2026